Learn about the global biosimilar growth hormones market through The Business Research Company, which provides information on biosimilar growth hormones market size, biosimilar growth hormones market drivers and restraints, biosimilar growth hormones market players, the COVID-19 impact on the biosimilar growth hormones market, and more.

The global biosimilar growth hormones market size is expected to grow from $0.59 billion in 2021 to $0.64 billion in 2022 at a compound annual growth rate (CAGR) of 8.4%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The biosimilar growth hormone market is expected to reach $0.89 billion in 2026 at a CAGR of 8.4%.

The growing number of children suffering from growth hormone deficiency is driving the growth of the global biosimilar growth hormone market.

Request A Sample For The Global Biosimilar Growth Hormones Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

The biosimilar growth hormone market consists of sales of Somatropin or human growth hormone (HGH) and related services by entities (organizations, sole traders and partnerships) that manufacture growth hormones. Biosimilar growth hormones are used to stimulate growth, cell reproduction and cell regeneration in humans and other animals.

Global Biosimilar Growth Hormones Market Segments Include:

By Route of Administration: Intravenous, Subcutaneous, Intramuscular, Oral

By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Others

By Distribution Channel: Hospital and Retail Pharmacy, Online Pharmacy/ePharmacy, Speciality Clinics

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the biosimilar growth hormone market in 2021.

Recombinant DNA technology (rDNA technology) is increasingly being implemented in the biosimilar growth hormone industry. The development of biosimilar growth hormone by using rDNA technology is an emerging trend.

TBRC’s biosimilar growth hormones market report covers:

Major Market Players: Biopartners And LG Chem, Amega Biotech, Eli Lilly and Company, Genetech Inc., Novartis AG, Zhongshan Hygene Biopharm Co. Ltd., Merck, Sanofi S.A., Biosidus and Ferring Pharmaceuticals.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Biosimilar Growth Hormones Global Market Report 2022–Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides biosimilar growth hormones market overviews, analyses and forecasts market size, share, biosimilar growth hormones market players, biosimilar growth hormones market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s biosimilar growth hormones market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Biosimilar Hormones Global Market Report 2022

Biosimilar Lymphocyte Modulator Global Market Report 2022

Biosimilar Therapeutic Peptides Global Market Report 2022

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: